Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CVS HEALTH CORPORATION

(CVS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

CVS Health, Walgreens, Rite Aid Offering Pfizer COVID-19 Vaccine to Adolescents

05/13/2021 | 02:05pm EDT


ę MT Newswires 2021
All news about CVS HEALTH CORPORATION
06/17Healthcare industry prepares for Obamacare expansion after court ruling
RE
06/17CVS HEALTHá : expands partnership with Cardtronics to offer surcharge-free ATMs ..
AQ
06/17CARDTRONICSá : to Launch Allpoint ATMs at 50 CVS-Operated Longs Drugs Locations ..
MT
06/15CVS HEALTHá : Pharmacy announces major update to ExtraCare Rewards program, deli..
PU
06/11CVS HEALTHá : Aetna Better Health Premier Plan MMAI approved to expand statewide..
PR
06/10CVS HEALTH CORPá : Change in Directors or Principal Officers (form 8-K)
AQ
06/10CVS HEALTHá : RBC Boosts Price Target on CVS Health to $101 From $91, Maintains ..
MT
06/09CVS HEALTHá : Opens First MinuteClinic Locations in Utah as part of Nationwide E..
PR
06/08CVS HEALTHá : signs Human Rights Campaign's Business Statement Opposing Anti-LGB..
PU
06/08Amazon Pharmacy offers half-yearly prescriptions starting at $6
RE
More news
Financials (USD)
Sales 2021 282 B - -
Net income 2021 8 247 M - -
Net Debt 2021 50 206 M - -
P/E ratio 2021 13,3x
Yield 2021 2,43%
Capitalization 108 B 108 B -
EV / Sales 2021 0,56x
EV / Sales 2022 0,52x
Nbr of Employees 256 500
Free-Float 75,6%
Chart CVS HEALTH CORPORATION
Duration : Period :
CVS Health Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CVS HEALTH CORPORATION
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 29
Average target price 96,15 $
Last Close Price 82,40 $
Spread / Highest target 29,9%
Spread / Average Target 16,7%
Spread / Lowest Target -1,70%
EPS Revisions
Managers and Directors
NameTitle
Karen S. Lynch President, Chief Executive Officer & Director
Shawn M. Guertin Chief Financial Officer & Executive Vice President
David Wyatt Dorman Chairman
Troyen A. Brennan Chief Medical Officer & Executive Vice President
Jonathan C. Roberts Chief Operating Officer & Executive Vice President
Sector and Competitors